Astellas Pharma, Inc. (ALPMY)
14.67
+0.22
(+1.52%)
USD |
OTCM |
May 08, 16:00
Astellas Pharma Total Liabilities (Quarterly) : 10.91B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 117.21B |
| Takeda Pharmaceutical Co., Ltd. | 49.54B |
| Daiichi Sankyo Co., Ltd. | 13.47B |
| Eisai Co., Ltd. | 3.640B |
| Chugai Pharmaceutical Co., Ltd. | 2.246B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.42B |
| Shareholders Equity (Quarterly) | 11.51B |
| Debt to Equity Ratio | 0.3091 |
| Current Ratio | 1.167 |
| Net Debt Paydown Yield | 2.07% |